SCHEMBL30747862

SCHEMBL30747862

COCOc1cc(CO)c2ccccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.37
AKR1B1 P15121 1/20 0.37
DHODH Q02127 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
CDC25B P30305 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
F2 P00734 2/20 0.35
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
RECQL P46063 1/20 0.35
PARP15 Q460N3 1/20 0.35
PARP10 Q53GL7 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29151462 1.00 GRM5 (0.37) GRM5AKR1B1DHODHMEN1KMT2A
SCHEMBL2806149 0.84 MEN1 (0.37) AKR1B1MEN1KMT2ATDP1MTNR1A
SCHEMBL8965862 0.83 AKR1B1 (0.50) AKR1B1MEN1KMT2ATDP1CDC25B
SCHEMBL23043017 0.82 NQO2 (0.52) GRM5AKR1B1TDP1CDC25BKDM4E
SCHEMBL30391379 0.82 NQO2 (0.52) GRM5AKR1B1TDP1CDC25BKDM4E
SCHEMBL30182306 0.81 GRM5 (0.37) GRM5CDC25BCYP1A2CYP2A6NQO1
SCHEMBL25991555 0.81 GRM5 (0.37) GRM5CDC25BCYP1A2CYP2A6NQO1
SCHEMBL19637220 0.80 CYP1A2 (0.48) GRM5CDC25BL3MBTL1ALDH1A1LMNA
SCHEMBL19616662 0.79 CYP1A2 (0.36) GRM5TDP1CDC25BL3MBTL1KDM4E
SCHEMBL19616584 0.79 CYP1A2 (0.40) GRM5MEN1KMT2ATDP1CDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117466917-A Heterocyclic derivative, preparation method and medical application thereof 浙江海正药业股份有限公司 2024-01-30 CN disclosed